MENU
TMED
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

TMED stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
TMED
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TMED with price predictions
Aug 21, 2026

Momentum Indicator for TMED turns positive, indicating new upward trend

TMED saw its Momentum Indicator move above the 0 level on August 03, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned positive. In of the 15 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TMED just turned positive on August 10, 2026. Looking at past instances where TMED's MACD turned positive, the stock continued to rise in of 15 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMED advanced for three days, in of 64 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 67 cases where TMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TMED moved out of overbought territory on August 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMED broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Gilead Sciences (NASDAQ:GILD).

Industry description

The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.

Market Cap

The average market capitalization across the T. Rowe Price Health Care ETF ETF is 230.53B. The market cap for tickers in the group ranges from 4.87B to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is DYN at 4.87B.

High and low price notable news

The average weekly price growth across all stocks in the T. Rowe Price Health Care ETF ETF was 8%. For the same ETF, the average monthly price growth was 22%, and the average quarterly price growth was 76%. DHR experienced the highest price growth at 8%, while UNH experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the T. Rowe Price Health Care ETF ETF was 36%. For the same stocks of the ETF, the average monthly volume growth was -24% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 31
P/E Growth Rating: 62
Price Growth Rating: 35
SMR Rating: 46
Profit Risk Rating: 64
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
TMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
100 EAST PRATT STREETBALTIMORE MD 21202
Phone
410-345-2000
Web
N/A